| Financial Year |
March 31 2023 |
| Monetary Funds |
726,146,223.63 |
| Held-for-trading Financial Assets |
2,827,487,540.29 |
| Notes Receivable |
-- |
| Accounts Receivable |
2,073,453,525.64 |
| Advances to Suppliers |
35,097,040.94 |
| Other Receivables |
8,447,789.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,639,580,655.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
410,000,000.00 |
| Other Current Assets |
265,985.27 |
| Total Current Assets |
7,788,606,531.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
44,635,582.07 |
| Investment Properties |
-- |
| Fixed Assetes |
2,037,934,280.26 |
| Under-construction Projects |
243,567,487.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
236,944.89 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
308,352,263.97 |
| R&D expenses |
24,276,738.96 |
| Goodwill |
1,098,329.80 |
| Long-Term Deferred and Prepaid Expenses |
15,669,964.49 |
| Deferred Income Tax Assets |
226,311,180.18 |
| Other Non-Current Assets |
4,380,728,007.85 |
| Sub-Total of Non-Current Assets |
7,292,722,613.78 |
| Total Assets |
15,081,329,145.54 |
| Short-Term Loans |
800,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,072,110.00 |
| Accounts Payable |
202,611,371.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
409,253.99 |
| Taxes Payable |
48,383,562.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,022,893,825.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
235,673.16 |
| Other Current Liabilities |
339,159.91 |
| Sub-Total of Current Liabilities |
2,096,254,085.23 |
| Long-term Loans |
300,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,257,803.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
384,925,259.16 |
| Total Liabilities |
2,481,179,344.39 |
| Paid-In Capital(Or Share Stock) |
1,824,366,726.00 |
| Capital Surplus |
1,420,111,709.11 |
| Surplus Reserve |
738,081,985.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,772,539,059.33 |
| Minority Stockholder's Interest |
1,845,050,320.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,755,099,480.27 |
| Owner's Equity（Stockholder's Equity） |
12,600,149,801.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,081,329,145.54 |
